Joseph Shulman - Feb 13, 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Signature
/s/ Hunter Smith, attorney-in-fact for Joseph Shulman
Stock symbol
RYTM
Transactions as of
Feb 13, 2024
Transactions value $
-$147,711
Form type
4
Date filed
2/15/2024, 06:14 PM
Previous filing
Nov 13, 2024
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Sale -$93.3K -1.87K -62.5% $50.00 1.12K Feb 13, 2024 Direct F1
transaction RYTM Common Stock Sale -$54.5K -1.09K -97.32% $50.01 30 Feb 14, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2023.